Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
51.41%
↑ 428% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthAccelerating
Average
-15.67%
Historical baseline
PeriodValue
202551.41%
2024-46.97%
2023-28.37%
2022-11.76%
2021-61.98%
2020-19.15%
2019-2.20%
2018-3.83%
2017-33.06%
2016-0.84%